Status:
COMPLETED
ERPS, BIS and Entropy for Neuromonitoring in ICU Patients
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
GE Healthcare
Conditions:
Deep Sedation
Electroencephalography
Eligibility:
All Genders
18+ years
Brief Summary
Most critically ill patients receive sedative and analgesic drugs to attenuate discomfort and pain. The excessive use of sedatives and analgesics has undesirable effects for patients. Whereas undersed...
Detailed Description
Most critically ill patients receive sedative and analgesic drugs to attenuate discomfort and pain. The excessive use of sedatives and analgesics prolongs time on mechanical ventilation, the incidence...
Eligibility Criteria
Inclusion
- 18 Years or older
Exclusion
- ASA class III or higher history of adverse events during former surgery or anesthesia, neurological impairment in the medical history hearing abnormalities.
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00639548
Start Date
November 1 2004
End Date
September 1 2007
Last Update
March 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departement of Intensive Care Medicine - University Hospital Bern - Inselspital
Bern, Switzerland, 3010